Cargando…
The Potential of CRISPR/Cas9 Gene Editing as a Treatment Strategy for Alzheimer’s Disease
Despite a wealth of knowledge gained in the past three decades concerning the molecular underpinnings of Alzheimer’s disease (AD), progress towards obtaining effective, disease modifying therapies has proven to be challenging. In this manner, numerous clinical trials targeting the production, aggreg...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6078432/ https://www.ncbi.nlm.nih.gov/pubmed/30090689 http://dx.doi.org/10.4172/2161-0460.1000439 |